Immunogenicity and safety of fractional dose yellow fever vaccination: A systematic review and meta-analysis
- 1 February 2020
- Vol. 38 (6) , 1291-1301
Abstract
No abstract availableKeywords
Funding Information
- South African Medical Research Council
- National Research Foundation of South Africa (106035, 108571, 111678)
- Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (211360/Z/18/Z)
This publication has 37 references indexed in Scilit:
- The nuts and bolts of PROSPERO: an international prospective register of systematic reviewsSystematic Reviews, 2012
- Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort StudyPLOS ONE, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic reviewVaccine, 2011
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- What is “quality of evidence” and why is it important to clinicians?BMJ, 2008
- Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority TrialPLOS ONE, 2008
- Yellow fever control in Cameroon: Where are we now and where are we going?BMC Medicine, 2008
- Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccineJournal of Experimental Medicine, 2007
- Yellow Fever: Epidemiology and PreventionClinical Infectious Diseases, 2007